Abstract
The coronavirus disease 2019 (COVID-19) pandemic made daily news of deaths. According to several studies, a significant number of deaths due to COVID-19 resulted from secondary bacterial infections. Consequently, antimicrobials are important tools in helping to defend against mortality in patients with COVOD-19. It should be noted that, antimicrobial resistance (AMR) is now estimated to cause notable global deaths. Points to consider that proportion of COVID-19 cases that are prescribed antibiotics are unclear and may be associated with patient injury and AMR. Thus, the aim of the current review was to focus on the role of antibiotic therapy in the treating of COVID-19.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
